Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2188
https://www.valueinhealthjournal.com/article/S1098-3015(16)33554-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2077
First Page :
A729
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33554-9&doi=10.1016/j.jval.2016.09.2188